Committee on Clinical Pharmacology and Pharmacogenomics

Fellows

Fellows in Committee on Clinical Pharmacology and Pharmacogenomics

Kunal Desai, MD, MBA, MS

Kunal Desai, MD, MBA, MS

Fellow, Committee on Clinical Pharmacology and Pharmacogenomics

Research Interest: De novo drug discovery in solid tumors; this includes the spectrum – from identifying novel targets to elucidating their mechanism of action to developing novel targeted therapies. 

Research Mentors: Russell Szmulewitz, MD

Jacobi Hines, MD

Jacobi Hines, MD

Fellow, Committee on Clinical Pharmacology and Pharmacogenomics

Research Interest: Optimization of cancer immunotherapies; specifically, combination therapies, predicting response and predicting/treating immune related adverse events.

Research Mentors: Pankti Reid, MD and Marina Chiara Garassino, MD.

Nabiel Mir, MD

Nabiel Mir, MD

Fellow, Committee on Clinical Pharmacology and Pharmacogenomics

Research Interest: Early phase clinical trials for vulnerable patients, geriatrics, AI and precision dosing, digital health.

Research Mentor: Russell Szmulewitz, MD

Marcel Bertsch-Gout, MD

Marcel Bertsch-Gout, MD

Fellow, Committee on Clinical Pharmacology and Pharmacogenomics

Research Interest: Early phase clinical trials; improving the side effect profiles of psychiatric medications by increasing receptor specificity and through pairing with

Research Mentors: Jon E. Grant, JD, MD

Joseph Cannova, MD, PhD

Joseph Cannova, MD, PhD

Fellow, Committee on Clinical Pharmacology and Pharmacogenomics

Research Interest: Investigating mechanisms of recurrent cytogenetic alterations in therapy-related myelodysplastic syndrome and acute myeloid leukemia with loss of chromosome 7 domains.

Research Mentors: Megan McNerney, MD, PhD 

Youngwoo Cho, PharmD

Youngwoo Cho, PharmD

Fellow, Committee on Clinical Pharmacology and Pharmacogenomics

Research Interest: Translation of pharmacogenomics (PGx) in clinical oncology, early-phase clinical development, and pharmacokinetics (PK) and pharmacodynamics (PD) of immunotherapy

Research Mentor: Peter H. O’Donnell, MD

Sabrina Imam, MD, PhD

Sabrina Imam, MD, PhD

Fellow, Committee on Clinical Pharmacology and Pharmacogenomics

Research Interest: Characterizing the intestinal microbiome and metabolome in people undergoing chemotherapy in hopes of identifying metabolites associated with favorable clinical outcomes and protection from infection

Research Mentors: Eric G. Pamer, MD

Danica Quickfall, MDCM

Danica Quickfall, MDCM

Fellow, Committee on Clinical Pharmacology and Pharmacogenomics

Research Interest: Understanding sedative and antimicrobial administration in critically ill patients. Focus on optimizing antimicrobial dosing in patients receiving continuous renal replacement therapy and novel routes of medication administration

Research Mentors: Jay Koyner, MD 

Robert Cameron, MD

Robert Cameron, MD

Fellow, Committee on Clinical Pharmacology and Pharmacogenomics

Research Interest: Identification of metabolic vulnerabilities within tumors to develop new therapeutic targets and combinations

Research Mentors: Brandon Faubert, PhD and Marina Garassino, MD